chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On Tuesday 4-13-10 i took my son to get his 4mos old vaccinations & proceeded to take him home- everything was fine all day long until that night when my son woke up SCREAMING and crying around 3:30am-I check temp & it was 105.3; gave Tylenol slowly went down, went back to see Pediatrician & she sent us home because she saw nothing wrong other then fever and told us to continue to try and keep fever down. later on in afternoon (spent all day trying to keep fever down) around 4:30pm my son had a full extremities seizure & we took him to hospital, he got a full CT scan, lumbar puncture -& they proceeded to run tests (suspecting meningitis) they transported him to another hospital that night and he proceeded to have 2-4 more seizures.. and he spent the next 72hr there awaiting test results & everything came back negative & they sent us home once the fever had been broken for longer then 24hr; he is now home, but now we worry about neurological damage?
1/27/22 pt admitted to Hospital for AMS; CXR showed probable bronchitis; CT head showed no acute findings; admitted; pt waiting for placement in a nursing home; 2/8/22 pt had a positive COVID test; family declined medications; pt dc'd to medical facility (nursing home) where he passed away
Directly after receiving the Pfizer vaccine, my arm went fully numb, was red and hot. I was advised to take allergy medication, which I did. My arm has been heavy and painful since. My throat is sore and I am fatigued.   *Not severe reactions, but I'd like to add reporting data for the younger generation. ** Also note that it has only been one day since receiving the first Pfizer vaccine
I unintentionally administered a Hepatitis A vaccine that expired on 6/18/22.
Diffuse itchy rash on hands, feet, groin, trunk, arms, and legs
since getting this unapproved vaccine I just don't feel the same anymore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (since getting this unapproved vaccine I just don't feel the same anymore) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (since getting this unapproved vaccine I just don't feel the same anymore). At the time of the report, VACCINATION COMPLICATION (since getting this unapproved vaccine I just don't feel the same anymore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided by the reporter. No treatment information was provided by the reporter.   Reporter did not allow further contact
Patient contacted and reported to this writer that her left arm was turning black. Patient informed this writer that her left arm had an itchy rash that started off as a burning sensation. It started as soon as the injection was administered. Per patient report, there is no swelling to the arm, no bleeding and full range of motion.
The patient received two FluMist doses in fall 2021 (8/30/21 and 10/06/21). She had attended two separate flu clinics with different parents.
c/o chest tightness, headache, chills, cold, muscle ache, throwing up since had J&J vaccine. took Motrin last night and this morning, 0900 but no changes. denies sob, abd pain, dizziness.
she had a high fever for a week. going up to 105 degrees; This spontaneous report was received via Pfizer from a currently 63 years old female patient reporting on herself. The patient's pertinent medical history included fever of 105F when she was a baby after receiving the Smallpox vaccine. Concurrent conditions included  hypersensitivity and concomitant medication was not provided.  On an unspecified date, when the patient was 9 years old, she was was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (manufacturer unknown) dose, route of administration, anatomical location, lot number and expiration date were not provided for prophylaxis.  On an unspecified date, the patient experienced a high fever for a week, going up to 105 degrees. The reporter stated that her physicians said that her body reacted "fairly strenuously to the introduction of foreign substances".  The outcome of pyrexia was unknown, the reporter did not assess the causal relationship between the fever and the vaccination with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (manufacturer unknown).
Large local erythematous, warm reaction (R) thigh afebrile. Acting normally. Treated for primary cellulitis w/redness worsening for 3 days with BACTRIM.
Case number PHEH2013US027051, is an initial spontaneous report received from a health care professional (who is also patient) via product technical complaint department (QA reference numbers: 257815 and 260059) on 22 Oct 2013. This report refers to a patient of unknown identifiers. The patient's medical history and concomitant medications were not reported. The patient was inadvertently exposed to FLUVIRIN (batch number: 1308401, expiry date: 30 mar 2014) which rundown the patient arm when the patient was drawing a dose form a vial after the seventh or eight puncture to the multiuse vial of FLUVIRIN. It was reported that there was significant leakage of vials. The patient used 23 gauge one inch needles which were standard for flu shot. The problem seemed to start after second of third needle when used in the same area where previous needle was punctured. After each successive needle punctured the stopper was leaking and got worse. It seemed like the rubber of the stopper was acting like it was old or had got frozen. There no damage of the original vial box (carton, packaging). No adverse events reported after the maladministration.
Tongue tingling, throat tightness @0520 Chest heaviness, lips numb @0525 Voice hoarseness @ 0530  IV Benadryl given approx 0550 PO prednisone given approx 1000  Left side of face still numb after 24 hours
Dizziness, paresthesia and vomiting after Pfizer booster. Went to ED; diagnosed with biphasic anaphylaxis and received treatment.
On consent form she checked No never received vaccine before but he had Moderna on 2/10 here at medical facility.
pt states she started feeling like she had the flu.  She was achy and had chills.  She developed a severe cough.  She contacted her PCP and was told to take Benzonatate cough tablet and Benadryl.  She had these symptoms about 6 days.
4 month old child was given MMRV (ProQuad) As of time of this report child does not appear to have any adverse reactions.
The evening of the vaccine, I experienced extreme fatigue, weakness, and chills. This continued into the following day and I developed a fever. I slept on and off for 16 hours and eventually took Children's Tylenol for the fever.
04/25/2022, I had a dry scratchy throat. The next day I started having a cough. That evening, I developed a fever and was down and out. I had fever, chills and body aches for one night. 4/29/2022, I called the doctor and they prescribed a Z-Pak and cough medicine. The cough is the worse thing I have had and I still have it, but seems better today. Not knowing what was going on, and having only had a telehealth visit with my doctor, I went to the pharmacy and had a COVID-19 test on 4/30/2022 and it came back on 5/1/2022 as positive.
This case was reported by a nurse via call center representative and described the occurrence of drug dose administration interval too long in a 56-year-old female patient who received TWINRIX. Concurrent medical conditions included hepatitis c. On an unknown date, the patient received TWINRIX at an unknown dose. On an unknown date, an unknown time after receiving TWINRIX, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown. Additional information: A patient received dose 1 on 11/24 and dose 2 on 12/1. She missed dose 3 because she was in the hospital (she is a hep C patient).
10 minutes after receiving COVID vaccine dose #2 complained of mild tongue tingling with no associated symptoms. Blood pressure 109/71. HR 68. Patient given 25 mg of Benadryl with good effect. Monitored for 30 minutes and was sent home in no distress. Called patient home to check her status, patient reported feeling well and safe.
Pt was accidentally administered a pediatric 10mcg dose then subsequently redosed with 20mcg to equate a full 30mcg dosage. Pt has not reported any adverse effects or symptoms from this error.
Fever chills headache muscle ache joint ache nausea vomiting diarrhea
p/vax pt c/o T103.8 & shaking chills;refused hosp adm;T104.6 R;adm to hosp;10/14/99 CXR showed ARDS & pneumonia;pt placed on ventilator;devel DIC;pt expired 10/25/99;
The day after patient was immunized she came down with diarreah & a fever of about 101 F. I called her pediatrician right away & she told me to give her over the counter fever reducing medicatons. She continued having moderate fever for the next few days. By 9/15/19 her temperature went down to 99.8 F. Then on Monday 9/16/19, her temperature spiked to 104.5 F. On Tuesday, 9/17/19, her fever was still very highest point of 104.2 F. I took her to the doctor & she did a troat culture which came up negative. Wednesday 9/18 she was very lethargic & was still having fever all day & in the evening her fever went up to 105.3 F. I gave her OTC fever medication & called the doctor right away  & Made an appointment for the following day. This morning 9/9/19 she was still having fever of about 101F. My doctor took bloodwork for a cbc & perscribed antibiotics.
Numbness started in left arm then spread to left leg. Pain back of left shoulder and under side of proximal left upper arm. Pain distal hamstring. No pain at injection site.
Headache Body ache, SOB sore arm, weakness, Narrative:  Her shortness of breath has improve. Still with HA and Body ache.
The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 203A21A expiry: UNKNOWN) dose was not reported, administered on 09-JUN-2021 for prophylactic vaccination. No concomitant medications were reported. On JUN-2021, the subject experienced tiredness. On JUN-2021, the subject experienced fatigue. On JUN-2021, the subject experienced lack of energy. On 12-JUN-2021, the subject experienced headache. On 12-JUN-2021, the subject experienced soreness in right arm at injection site. On 12-JUN-2021, the subject experienced pain in the muscle in upper arm. On 16-JUN-2021, the subject experienced dark red blood in left eye. On 20-JUN-2021, the subject experienced slight blurred vision in left eye. On 20-JUN-2021, the subject experienced sleeping more than usual. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the headache, dark red blood in left eye, tiredness, slight blurred vision in left eye, fatigue, lack of energy, sleeping more than usual, soreness in right arm at injection site and pain in the muscle in upper arm was not reported. This report was non-serious.
Approximately 1.5 hours after receiving the vaccine, patient returned to the pharmacy complaining of widespread hives and itching. She did not have shortness of breath. I administered 50mg of Benadryl and had her sit for 15 minutes. Benadryl reduced the hives and the patient left the store.
wobbling profusely as she walks out of a bathroom/getting even worse; This is a spontaneous report from non-contactable consumers from a Pfizer sponsored program Corporate (Pfizer) Social Media Platforms. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient had been injured by the vaccine. She was wobbling profusely as she walked out of a bathroom. She was admitted to the hospital and was cautious about taking the vaccine. She was getting even worse today (11Jan2021) and still did not have any answers from doctors as to how to fix this. The shots cause harm. Injury was real and not rare. She had a bad night last night but today was a little better for her. They still didn't know how to treat this problem. Magnetic resonance imaging (MRI) results came back good today (11Jan2021). She just had another serious episode and she thought it's getting worse when the shakes come. The outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sterile abscesses formed at each injection site 1 mo after vaccines were administered. Three cultures have been sent - all of which were negative. Abscesses are still present (-) this time.
neck to toe joint pain; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (neck to toe joint pain) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (neck to toe joint pain). At the time of the report, ARTHRALGIA (neck to toe joint pain) outcome was unknown.            Concomitant product details was not reported.  Treatment details was not reported .
Information has been received through a pregnancy registry from a physician concerning an approximately 29 year old female with an allergy to acetaminophen (+) oxycodone hydrochloride and a history of appendectomy and caesarean section in 1995. In approximately 1998, the patient was vaccinated with varicella virus vaccine live. In 1998, the patient had a termination of pregnancy for fetal disproportion syndrome secondary to varicella virus vaccine live administration. The reporter indicated that the patient was vaccinated with a dose of varicella virus vaccine live (lot # 641709/0330M) on 5/5/03 and on approximately 5/15/03 the patient found out she was pregnant. The patient was scheduled for termination of pregnancy on 5/23/03. Additional details concerning the possible termination of pregnancy are being sought. Additional information has been requested.  Received on 06/11/2003: "Follow up information received on 05/29/2003 indicated that the reporting physician had no further information on the patient, except that she had been counseld by him and by her OB/GYN that varicella virus vaccine live exposure was not reason to terminate the pregnancy.  However, he stated, "she had other risks".  They advised her to wait and receive further counseling but, he stated, she refused to wait.  He stated that during the previoius pregnancy she had received advice from the chief of staff at a hospital that the vaccine may have risks but he had no further information regarding that pregnancy.  It was also noted that the patient had been vaccinated as part of employee health requirements as she had a negative serostatus.  Additional details concerning the possible termination of pregnancy are still being sought.  Additional information has been requested.  Received on 06/17/2003: "Follow up information received on 05/29/2003 indicated that the reporting physician had no further information on the patient, except that she had been counseled by him and by her OB/GYN that varicella virus vaccine live exposure was not reason to terminate the pregnancy.  However, he stated, "she had other risks".  They advised her to wait and receive further counseling but, he stated, she refused to wait.  He stated that during the previous pregnancy she had received advice from the chief of staff at a hospital that the vaccine may have risks but he had no further information regarding that pregnancy.  It was also noted that the patient had been vaccinated as part of employee health requirements as she had a negative serostatus.  Additional details concerning the possible termination of pregnancy are still being sought.  Additional follow up information indicated that on 06/04/2003 the patient "has not done anything about the pregnancy yet".  Additional information has been requested.
Patient was administered the Moderna COVID vaccine and patient is only 15 years of age. Patient has not had any adverse effects. This is being reported as an administration error.
pt recv vax 5OCT98 &  7OCT98 pt devel a pruritic rash which was dx as erythema mult;9OCT98 pt was seen by MD & placed on med;
I received the vaccine and was unknowingly pregnant. My first shot was on 1/6/2021 and my second shot was on 1/27/2021. I conceived on  1/25/2021. I ended up miscarrying the child and when they sent it in for testing it had 2 abnormal chromosomes. One of which they said is very rare and they have no idea how or why the baby had this. I was told that the vaccine was supposed to be safe for pregnant people but with no family history of anything like this happening and no history of any children being born with mutations I believe this happened from the vaccine. Possibly caused by the spike in temperature I experienced after the second shot. I should have been due to deliver 10/2021.
Itching and swelling on the left arm, large red welt. Appeared approximately 6 days after receiving the vaccine. Flares up during physical activity.
Awoke in the morning with tinnitus in left ear only.  Tinnitus has been present continuously since first onset.
COVID-19; COVID-19; Soreness; Bronchitis; This is a solicited report from a Non-Interventional Study (FACILITATED COLLECT) based on information received by Pfizer from AbbVie. A contactable consumer (patient) reported that a 58-year-old male patient of an unspecified age received bnt162b2, intramuscularly on 20Apr2021 (Batch/Lot number was not reported) at the age of 57-year-old as dose 1, single, intramuscularly on 20May2021 (Batch/Lot number was not reported) at the age of 57-year-old as dose 2, single for covid-19 immunization; adalimumab (HUMIRA, Solution for injection in pre-filled pen), subcutaneously from an unspecified date (Batch/Lot number was not reported) and ongoing, at unknown dose (CF) for moderate to severe chronic plaque psoriasis. The patient's medical history and concomitant medications were not reported. The patient experienced covid-19 on 20Aug2021 with outcome of unknown, soreness in 2021 with outcome of unknown, bronchitis in 2021 with outcome of not recovered. Solicited report by a consumer of a 58 years old male with events of non-serious covid-19 Pfizer Booster caused soreness, bronchitis and-COVID-19 with adalimumab (HUMIRA). There was no reported medical history. On an unknown date, the patient experienced bronchitis. In 2021, the patient experienced COVID-19 Pfizer booster caused soreness. On 20Aug2021, the patient experienced COVID-19. Pfizer Biontech covid-19 vaccine (TOZINAM-ERAN) was also considered suspect. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. On 20Apr2021, he received 1st dose COVID-19 Vaccine manufactured by Pfizer/BioNTech. On 20May2021, he received 2nd dose COVID-19 Vaccine manufactured by Pfizer/BioNTech. The action taken in response to the events for adalimumab was dose not change.  Causality for HUMIRA(ADALIMUMAB): The reporter's causality for the event(s) of covid-19 Pfizer booster caused soreness, bronchitis and covid-19 with HUMIRA(ADALIMUMAB) was no reasonable possibility. Causality for Pfizer Biontech covid-19 vaccine (TOZINAMERAN): The reporter's causality for the events of soreness with bnt162b2 was Probable, for bronchitis and covid-19 was not reported.  The reporter's assessment of the causal relationship of the events (bronchitis and covid-19) with bnt162b2 was not provided at the time of this report. Since no determination has been received, the case is managed based on the company causality assessment.  The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: Based on available information and the drug temporal relationship, the causality between the reported events Drug ineffective, suspected COVID-19,pain, Bronchitis and  the suspect drug "BNT162B2" cannot be completely excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Shortness of breath. I need to gasp for air, comes and goes since it first started. I tried taking mucinex thinking it will decongest my chest for better breathing, worked slightly. When it came back in a couple of days I took benadryl but didn?t help much.
Arm swelling  Headache  Fever  Joint aches Left hand numbness  Could not stay awake  Generalized body aches
Patient stated a few hours after receiving he started feeling "bad". He states he woke up the next morning with chest tightness and slight dyspnea. He sated he was dizzy and had body aches. They resolved by afternoon with rest.
tinnitus; This case was reported by a physician via sales rep and described the occurrence of tinnitus in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced tinnitus. On an unknown date, the outcome of the tinnitus was not recovered/not resolved.   It was unknown if the reporter considered the tinnitus to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was selected as adult as per vaccine indication. The physician reported to the sales representative the patient in the late 50s to early 60s developed tinnitus. No additional information was available regarding the patient. The reporter consented to follow up. This case has been linked with US2019AMR158102, having same reporter.
thoracic spine pain a few hrs after 2nd vaccine. persistent for a few weeks, then severe chest pain, resulting in ER visit and hospital admission. final diagnosis myocarditis. discharged in stable condition.
Initial information received on 04-Feb-2019 regarding an unsolicited valid non-serious case received from a physician. This case involves unknown demographic patient who experienced allergies to tetanus toxoid fluid, while he/she received vaccine TETANUS TOXOID. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a dose of suspect TETANUS TOXOID produced by unknown manufacturer lot number, Exp. Date, dose, route and administration site not reported. On an unknown date, the patient developed non-serious allergy to tetanus toxoid fluid following the administration of TETANUS TOXOID. Details of lab data not provided. Final diagnosis was allergy to tetanus toxoid fluid. It was not reported if the patient received any corrective treatment. The event outcome was not reported. List of documents held by sender: none.
mom c/o persistent nodule @ site of IPV rt thigh 2 to 3mm;pt had larger erythematous nodule @ the site;